Company intelligence

CHE

Chemed Corporation · NYSE · Healthcare

Price$548.56+0.84% · +$4.58

Market cap7.17BEquity value

P / E25.4Trailing ratio

Volume128.65KLatest session

Market data

CHE price chart

TradingView

Related signals

1 min delayed

Browse public CHE signals with their source context and measured market impact. Open any signal for its permanent analysis page.

CHEJul 24, 2024-1.19% since signal

Chemed (CHE) Misses Q2 Earnings and Revenue Estimates

CHE's Q2 earnings missed expectations at $5.47 per share. Revenue grew to $595.88 million, but still below estimates. CHE shares declined 7.4% year-to-date, underperforming the S&P 500. The stock currently holds a Zacks Rank #3 (Hold). Future stock movements are linked to earnings estimate revisions.

View signal analysis

CHEApr 24, 2024-7.22% since signal

Chemed (CHE) Q1 Earnings Miss Estimates

- Chemed's quarterly earnings were below estimates at $5.20 per share, with 4.94% earnings surprise. - Revenues for the quarter ended March 2024 were $589.23 million, surpassing estimates by 0.35%. - Chemed stock's immediate price movement will depend on future earnings expectations and management's commentary. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

View signal analysis

Research